ENDONOVO THERAPEUTICS, INC. (ENDV) — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)

$135.4K

Net Income/Loss (FY2022)

-$18.5M

Total Assets (FY2022)

$1.3M

Total Equity (FY2022)

-$32.2M

Cash Flows from Operating Activities (FY2022)

-$678.8K

Source: ENDONOVO THERAPEUTICS, INC. 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.